| Financial Year |
March 31 2023 |
| Monetary Funds |
3,623,205,768.68 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
334,202,559.46 |
| Accounts Receivable |
1,990,950,256.04 |
| Advances to Suppliers |
401,803,604.79 |
| Other Receivables |
28,929,951.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,793,435,546.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
102,317,739.61 |
| Total Current Assets |
8,502,757,082.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
81,080,702.15 |
| Investment Properties |
-- |
| Fixed Assetes |
2,982,561,951.47 |
| Under-construction Projects |
392,068,421.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
336,159,924.29 |
| R&D expenses |
-- |
| Goodwill |
20,310,091.31 |
| Long-Term Deferred and Prepaid Expenses |
24,823,733.90 |
| Deferred Income Tax Assets |
237,777,988.22 |
| Other Non-Current Assets |
74,936,370.27 |
| Sub-Total of Non-Current Assets |
4,180,895,861.79 |
| Total Assets |
12,683,652,944.07 |
| Short-Term Loans |
673,953,477.78 |
| Trading Financial liabilities |
3,754,128.16 |
| Notes Payable |
2,585,917,926.65 |
| Accounts Payable |
2,145,911,523.65 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
121,647,009.96 |
| Taxes Payable |
129,948,750.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
133,508,734.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,653,723.03 |
| Other Current Liabilities |
260,304,811.40 |
| Sub-Total of Current Liabilities |
6,457,666,862.11 |
| Long-term Loans |
250,478,104.59 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
72,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
114,152,380.66 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
467,158,424.45 |
| Total Liabilities |
6,924,825,286.56 |
| Paid-In Capital(Or Share Stock) |
1,178,523,492.00 |
| Capital Surplus |
438,005,920.01 |
| Surplus Reserve |
241,841,352.06 |
| LESS:Treasury Stock |
200,202,436.53 |
| Undistributed Profits |
4,093,810,461.11 |
| Minority Stockholder's Interest |
7,345,243.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,751,482,414.06 |
| Owner's Equity（Stockholder's Equity） |
5,758,827,657.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,683,652,944.07 |
